Loading...
OTCM
BVNRY
Market cap2.53bUSD
Oct 08, Last price  
11.48USD
1D
3.52%
1Q
23.44%
Jan 2017
-0.61%
Name

Bavarian Nordic A/S

Chart & performance

D1W1MN
OTCM:BVNRY chart
P/E
12.63
P/S
2.81
EPS
18.17
Div yield, %
—
Shrs. gr., 5y
7.62%
Rev. gr., 5y
27.21%
Revenues
6.17b
+7.96%
175,292,000332,103,000208,805,00074,783,000314,072,000523,601,0001,016,636,0001,212,501,0001,216,815,0001,020,561,0001,006,742,0001,370,151,000500,617,000662,488,0001,852,383,0001,897,875,0003,150,793,0007,062,340,0005,716,206,0006,171,025,000
Net income
1.38b
+39.21%
-160,937,000-63,504,000-216,242,000-395,988,000-576,969,000-324,339,000-240,001,000-46,729,00025,940,00059,426,00030,600,000181,343,000-361,927,000-346,777,000277,521,000-464,775,000-347,382,0001,475,189,000987,977,0001,375,378,000
CFO
2.72b
+39.60%
-194,493,000163,165,00022,411,000-484,139,000-239,862,000-375,236,00020,100,000147,084,000338,749,000105,323,000267,601,000216,065,000-288,529,000-275,910,000571,911,000-358,500,000220,053,0001,119,206,0001,949,832,0002,721,903,000
Dividend
Mar 27, 20200.59345 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Bavarian Nordic A/S engages in the business of developing, manufacturing, and commercializing cancer immunotherapies and vaccines for infectious diseases. The firm is involved in cancer immunotherapy including cancer pipeline, which focuses on therapeutic vaccines for breast, lung, ovarian, and prostate cancer. The company was founded on July 1, 1992 and is headquartered in Hellerup, Denmark.

Key people

Independent Chairman of the Board · since 2025
Paul Chaplin
President, Chief Executive Officer · since 2014
Heidi Hunter
Independent Vice Chairman of the Board · since 2025
Russell Thirsk
Executive Vice President, Chief Operating Officer · since 2022
Henrik Juuel
Executive Vice President, Chief Financial Officer · since 2018
Jean-Christophe May
Executive Vice President, Chief Commercial Officer · since 2020
Linette Andersen
Director, Employee Elected · since 2021
Thomas Bennekov
Director, Employee Elected · since 2021
Anja Gjol
Director, Employee Elected · since 2021
Karen Jensen
Director, Employee Elected · since 2021
Montse Montaner
Independent Director · since 2024
Johan van Hoof
Independent Director · since 2023
Independent Director · since 2016
IPO date
Nov 02, 1998
Employees
1,354
Domiciled in
DK
Incorporated in
DK
Headquarters & legal address
PHILIP HEYMANS ALLE 3
HELLERUP, 84 2900
DK

Valuation

Title
DKK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT